(19)
(11) EP 4 522 209 A1

(12)

(43) Date of publication:
19.03.2025 Bulletin 2025/12

(21) Application number: 23727473.3

(22) Date of filing: 11.05.2023
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/12; C12N 2760/18334; C12N 2760/18322; A61P 31/14
(86) International application number:
PCT/EP2023/062652
(87) International publication number:
WO 2023/217988 (16.11.2023 Gazette 2023/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 12.05.2022 EP 22173131

(71) Applicant: MSD International Business GmbH
6005 Luzern (CH)

(72) Inventors:
  • LANGEDIJK, Johannes, Petrus, Maria
    2333 CN Leiden (NL)
  • BAKKERS, Mark, Johannes, Gerardus
    2333 CN Leiden (NL)
  • RITSCHEL, Tina
    2333 CN Leiden (NL)
  • JURASZEK, Jaroslaw
    2333 CN Leiden (NL)

(74) Representative: Merck Sharp & Dohme LLC 
120 Moorgate
London EC2M 6UR
London EC2M 6UR (GB)

   


(54) STABILIZED PRE-FUSION HMPV FUSION PROTEINS